Wednesday, June 02, 2021 5:58:50 PM
The filings are due mid June, and they can file whenever they want. Outside of Q2 2020, they have filed every quarter on the day they were due or within the extension deadline, so by your theory, every quarter outside of Q2 2020 was bad? If that's what you think, then why would you buy? If you can't even follow your own investment strategy, why should anyone listen to your opinion?
For me, it's crystal clear the company is growing. When a company grows it sometimes takes time to see the share price catch up to the business's fundamentals especially on an exchange like the OTC where hype/spam/pumps lead the charge and other companies fall to the wayside.
KAVL is going to start distributing on an international level in the next few quarters. That means higher revenue.
The company is the fastest growing ENDs disposable product in the US, that means it has a competitive advantage and is better than all other products in the same category in growth.
The company just signed a new deal worth $22.4M in revenue for a test order, that means it's revenue in ADDITION to their repeat business. What happens if the inventory sells quick and the stores want more? Is it too hard to believe that the order won't become $30M, $40M, $50M over time?
The company has re-affirmed $400M+ for the full year, so show me why we shouldn't trust them to hit that. If they land in the $75M range, that's double what it was in Q1. That means they only need roughly a 50% growth in Q3 and Q4 to hit $400M.
If you're blind to the strides the company is making, then maybe you should read through their filings and PRs.
"Everything in existence is based on exact proportion and perfect relationship. There is no chance in nature, because mathematical principles of the highest order lie at the foundation of all things. There is nothing in the Universe but mathematical point
Recent KAVL News
- Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 10:15:33 PM
- Kaival Brands Provides Business Update in Letter to Shareholders • GlobeNewswire Inc. • 02/14/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:54:48 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/29/2024 10:10:18 PM
- Kaival Brands Partner Bidi Vapor to Contest FDA Denial of ‘Classic’ Tobacco-Flavored ENDS • GlobeNewswire Inc. • 01/29/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:14:06 PM
- Kaival Brands Innovations Group Announces Reverse Stock Split • GlobeNewswire Inc. • 01/23/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 02:00:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/16/2024 05:15:25 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 01/12/2024 10:21:13 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/12/2024 02:59:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:15:44 PM
- Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President • GlobeNewswire Inc. • 12/28/2023 01:30:00 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/22/2023 01:00:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/12/2023 09:16:14 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/12/2023 09:05:37 PM
- Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel • GlobeNewswire Inc. • 12/07/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:31:02 PM
- Kaival Brands Expands Senior Management Team with the Appointment of Barry Hopkins as Executive Chairman • GlobeNewswire Inc. • 11/13/2023 01:15:00 PM
- Kaival Brands Leads the Way in Compliance as FDA Ramps Up Enforcement of Illicit Vape Products • GlobeNewswire Inc. • 11/07/2023 01:15:00 PM
- Kaival Brands Innovations Group, Inc. Highlighted in Updated Research Report Released by Harbinger Research, LLC • GlobeNewswire Inc. • 10/12/2023 03:51:16 PM
- Kaival Brands to Present at the Fall Foliage MicroCap Rodeo Conference • GlobeNewswire Inc. • 10/09/2023 08:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM